North Carolina’s local governments will receive approximately $1.3 billion from national opioid settlements, following a new agreement announced Monday between Pennsylvania-based pharmaceutical firm Mylan and 15 states. The latest deal, valued at up to $335 million, includes as much as $9 million for North Carolina to be paid over the next nine years.
Respiratory Syncytial Virus (RSV) vaccines from GSK and Pfizer will carry warnings for an increased risk of Guillain-Barré syndrome (GBS), the U.S. Food Drug Administration (FDA) said.
A team of high school students from Centreville High School in Virginia, collaborating with the FDA, has uncovered concerning levels of DNA contamination in Pfizer’s experimental and commercial mRNA COVID-19 vaccines.
BioNTech has entered into two separate settlement agreements with the U.S. National Institutes of Health and the University of Pennsylvania regarding royalty payments for its COVID-19 vaccine.
Ford Motor Co. announced Monday it is donating $1 million and a fleet of vehicles to support President-elect Donald Trump's upcoming January inauguration.
Authorities in West Tennessee have seized hundreds of vials of black-market weight-loss drugs during a series of searches at a residence and two clinics, following a two-month investigation.
The United States District Court for the Northern District of Texas has issued a decisive ruling against the Food and Drug Administration (FDA) in a significant case brought by the Public Health and Medical Professionals for Transparency (PHMPT).
